why choose us

First received: February 20, 2026

Clinical Trial: Serum Endocan, Alarin, and Galanin-Like Peptide Levels in Diabetic Retinopathy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Diabetic Retinopathy

Study Type: INTERVENTIONAL


Official Title: Association of Serum Endocan, Alarin, and Galanin-Like Peptide Levels With Diabetic Retinopathy Stages and Optical Coherence Tomography (OCT) Findings

Brief Summary: This prospective cross-sectional study aims to evaluate the association between serum endocan, alarin, and galanin-like peptide levels and the stages of diabetic retinopathy (DR), as well as their relationship with optical coherence tomography (OCT) findings.A total of 120 participants will be included: 30 patients without diabetic retinopathy, 30 with non-proliferative diabetic retinopathy, 30 with proliferative diabetic retinopathy, and 30 healthy control subjects.In addition to routine preoperative blood…

Read more